Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Common Equity (2016 - 2025)

Historic Common Equity for Xtant Medical Holdings (XTNT) over the last 17 years, with Q3 2025 value amounting to $50.4 million.

  • Xtant Medical Holdings' Common Equity rose 1018.7% to $50.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.4 million, marking a year-over-year increase of 1018.7%. This contributed to the annual value of $43.0 million for FY2024, which is 1633.14% down from last year.
  • Latest data reveals that Xtant Medical Holdings reported Common Equity of $50.4 million as of Q3 2025, which was up 1018.7% from $48.5 million recorded in Q2 2025.
  • In the past 5 years, Xtant Medical Holdings' Common Equity registered a high of $54.7 million during Q3 2023, and its lowest value of $28.1 million during Q2 2022.
  • In the last 5 years, Xtant Medical Holdings' Common Equity had a median value of $34.2 million in 2022 and averaged $39.4 million.
  • Data for Xtant Medical Holdings' Common Equity shows a peak YoY increase of 17231.21% (in 2021) and a maximum YoY decrease of 3197.93% (in 2021) over the last 5 years.
  • Xtant Medical Holdings' Common Equity (Quarter) stood at $30.9 million in 2021, then increased by 10.65% to $34.2 million in 2022, then soared by 50.27% to $51.3 million in 2023, then fell by 16.33% to $43.0 million in 2024, then rose by 17.27% to $50.4 million in 2025.
  • Its Common Equity stands at $50.4 million for Q3 2025, versus $48.5 million for Q2 2025 and $43.9 million for Q1 2025.